Delist

    退市

    迈瑞医疗周四完成价值33亿美元的私有化交易，这宗27.94美元每股的交易完成意味着迈瑞医疗在纽交所的股票MR就此终止交易。

    Mindray Medical International Ltd. has become the latest Chinese company to delist from an American exchange after completing a US$1.9 billion privatization deal as a record wave of buyouts continues this year.

    The Shenzhen-based medical device maker has merged with Solid Union Ltd., a unit of Excelsior Union Ltd., based an offering price of US$28 per American depositary receipts (ADRs), according to a statement Friday.

    报道中的delist就是“摘牌、退市”。例如：

    These delist-relist deals have a similar underlying logic, that PE firms can turn American muck into brass in China.

    这类退市回归交易背后的逻辑都差不多，就是私募投资公司能够将美国的垃圾在中国变成宝贝。